In the United States
Dr Reddys Laboratories announced that the US Securities Class Action Lawsuit has been served on the Company in the U.S. by the lead plaintiff.The Company believes that the asserted claims are without merit and intends to vigorously defend itself against the allegations.
Powered by Capital Market - Live News
Disclaimer: No Business Standard Journalist was involved in creation of this content
